AI Article Synopsis
- The dimorphic fungus is a common cause of fungal infections in the U.S. and other regions, with symptoms ranging from none at all to severe systemic issues, often affecting the lungs but sometimes spreading to other parts of the body.
- Diagnosis is confirmed through fungal culture of tissue and fluids, while treatment typically involves azole antifungals like itraconazole, or amphotericin B for severe cases.
- The case study involves a young male with pulmonary blastomycosis who had a long incubation period and persistent symptoms, but after further testing and treatment, he made a full recovery.
Article Abstract
The dimorphic fungus , is one of the most frequent causes of endemic fungal infections in the United States as well as various other parts of the world. Clinical presentations vary widely, ranging from asymptomatic to disseminated systemic infections. Blastomycosis usually has a predilection for the lungs, but extra pulmonary manifestations are present in 25-40% of cases, involving the skin, bone, genitourinary tract, and CNS. A fungal culture of tissue specimens and fluids is confirmatory. The mainstay of treatment are the azole antifungals, i.e., itraconazole, and for disseminated disease, amphotericin B. We present a case of a young male with pulmonary blastomycosis who presented with a long incubation period. The non-resolving nature of his symptoms prompted further lab and imaging studies, ultimately leading to full and successful recovery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491499 | PMC |
| http://dx.doi.org/10.7759/cureus.44733 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!